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Exercise testing in patients with cystic fibrosis: Why and which?1. Implications of an exercise test
While the determination of exercise capacity is viewed as
clinical best practice in cystic fibrosis (CF), its measurement using
a cardiopulmonary exercise test (CPET) remains as somewhat of
a mystery for many CF clinicians. Two studies [1,2] in the current
issue (of the Journal of Cystic Fibrosis) highlight the use of
exercise testing in CF clinical practice. The role of retained
exercise capacity (VO2max) and levels of physical activity in CF in
maintaining health status is compelling. Using an accelerometer
to determine levels of physical activity, Hebestreit et al. [3] found
that more physically active CF patients had best preserved
VO2max, FEV1 and nutritional status. These results are supported
by a more recent review by Wilkes and colleagues [4] who
reported that children with CF with increased activity demon-
strated a reduced decline in pulmonary function.
To date we know that there is a clear relationship between
pulmonary dysfunction and exercise capacity in patients with
CF i.e. those with more severe pulmonary disease have lower
exercise capacity [5]. Interestingly the relationship between
VO2max and the extent of radiological damage (modified Bhalla
score on thin section chest HRCT) was stronger than with
spirometry or body mass index [6] which suggests that the
simple physiological measures used in the clinic setting may not
be sufficiently sensitive to detect subtle changes in the lungs and
in particular the airway. It has been suggested that in patients
with mild pulmonary disease, parameters of exercise at peak or
maximal performance may detect disease not identified by
routine lung function testing [7]. Additional parameters
obtained during formal exercise testing can therefore be useful
in patients with CF. An example in children with CF; was the
finding that the retention of CO2 during exercise was associated
with more rapid decline in pulmonary function [8].
The study by GRUET et al. [1] highlights the usefulness of
using CPET in CF and in particular the robustness of the oxygen
uptake efficiency slope (OUES). The OUES, first described by
Baba et al. [9] in the Journal of American College of Cardiology
in 1996, has proven to be a useful measure in a number of
clinical populations. In heart failure patients for example, the
OUES has proven to be a valid substitution for maximal
exercise capacity (VO2max) [10] and changes in OUES with
exercise training have are well correlated with changes in other
exercise related outcome measures [11].1569-1993/$ - see front matter © 2010 European Cystic Fibrosis Society. Publishe
doi:10.1016/j.jcf.2010.05.005While much of the focus on CPET in clinical populations has
been the determination of maximal (VO2max) or peak oxygen
consumption, the results of GRUET et al. [1] highlight the
importance of obtaining other important exercise related
measures during CPET and that the OUES can be assessed
during a sub-maximal exercise test. Measures such as the
anaerobic threshold (also known as the lactate or gas exchange
threshold—GET) can also be determined during an incremental
CPET. Similarly the relationship between ventilation (VE) and
carbon dioxide production (VCO2) (VE/VCO2 slope) can also
be simply extracted from incremental exercise tests. Indeed,
chronic heart and lung disease patients, VE/VCO2 has proven to
be a useful prognostic indicator. In over 450 chronic heart
failure patients followed for 2 years, Arena et al. [12] developed
a prognostic indicator for VE/VCO2. Individuals with the
steepest VE/VCO2 had the highest risk of mortality. As a result,
a clinical algorithm was developed to determine the appropriate
program of clinical management for chronic heart failure based
on CPET outcomes.
The OUES represents the rate of increase in oxygen uptake
(VO2) in response to given ventilation (VE) or in other words it
indicates how efficiently oxygen is extracted across the range of
ventilations achieved during incremental exercise. Physiolog-
ically, the OUES is based two factors (i) on the development of
metabolic acidosis, which is determined by the distribution of
blood flow to the skeletal muscles and (ii) the change in
physiological dead space which is affected by perfusion to the
lungs [9]. Hence for CF patients the OUES represents an ideal
index for changes in oxygen transport from the lungs to the
exercising muscle. Gruet and colleagues [1] found the OUES
more easily detectable than the GET, confirming the results of
earlier studies [9]. Therefore there is strong potential for the
OUES to be used in a more widespread manner in the clinical
setting for CF. While normative data are still be established for
OUES, it appears a simple and robust measure, which does not
need to be determined under maximal exercise conditions.
Several studies have examined the relationship between
measures of exercise capacity and prognosis in CF. Higher
levels of aerobic fitness in patients with CF was associated with
a significantly lower risk of dying [13]. Aerobic fitness may be a
marker for less severe illness; however the authors suggested
that measurement of VO2max appeared to be valuable for
predicting prognosis. In a five year observational studyd by Elsevier B.V. All rights reserved.
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and the ventilatory equivalent for oxygen (VE/VO2) were
related to survival, however, these indices were not overall
better than FEV1 in predicting survival. In contrast, parameters
derived from six minute walk tests in adults with severe CF lung
disease listed for lung transplantation, did not predict mortality
in a multiple regression analysis [14]. Resting heart rate was the
only predictor of the risk of death in this cohort of adult patients.
Further studies in patients with CF are needed to understand
the relationship between exercise parameters and clinical
outcomes, particularly in the utilisation of parameters derived
from sub-maximal exercise tests. Such studies could evaluate
the utility in detecting mild pulmonary disease in younger
children with CF, the sensitivity of exercise as a method of
detecting disease progression and its role as a method of
monitoring treatment response.
2. Exercise testing in the CF clinic
In CF, CPET remains an underutilised clinical measure. The
study by STEVENS et al. [2] highlights that despite the UK CF
Standards of Care Guidelines, which recommends annual
assessment, the use of exercise is limited both in terms of
assessing or intervening with patients. This study suggests that
many CF centres in the UK do not have access to formal
exercise testing facilities. This is likely to be compounded by
the logistic limitations of available space and need for
coordination of large numbers of patients who often have
tremendous pressures placed upon them when attending the
outpatient clinic. The relative importance placed on the
assessment of exercise capacity varies considerably between
CF centres even when facilities are readily available.
The reasons for limited utilisation of CPET in CF
populations include factors such as the requirement for
specialised exercise testing equipment and physical space to
perform the tests, inadequate health care rebate, lack of facilities
and resources including trained staff and inconclusive evidence
to date of the clinical usefulness of performing CPET in CF. The
burden of health maintenance therapies, frequent visits to the
hospital and the need to extensive investigations are also likely
to limit uptake of formal CPET. This has contributed to studies
of the validation of various alternative methods to determine
exercise capacity in CF populations and include: incremental
and endurance exercise testing, timed walking tests, shuttle
tests, step tests, etc.
3. Exercise testing and its relationship to exercise
prescription for patients with CF
Physical training is thought to be an important component of
the health maintenance for people with CF. A recent systematic
review of exercise training in CF examined the role of aerobic,
strength and anaerobic interventions in children and adults [15].
In summary, these trials demonstrate that both aerobic and
strength training increase pulmonary function, strength and
aerobic capacity [15]. Other benefits may include a positive
impact diabetes control, body image and levels of anxiety.Whilst studies are limited in both size and duration and include
a range of physical training interventions, there is no evidence
to discourage exercise as a part of a long term strategy for
maintaining health in persons with CF. There is some evidence
to suggest increased habitual activity slow the rate in decline of
lung function and regular exercise may lead to greater treatment
adherence in the longer term [16].
An important study finding by STEVENS et al. is the limited
utilisation of exercise training for patients with CF in the UK.
Whilst, exercise activity is commonly discussed in paediatric
and adult CF clinics at routine appointments the prescription of
formal exercise recommendations is limited (10.0–12.5% of
specialist clinics). It far more common for clinics to generally
encourage exercise activity than provide formal programs!
An assessment of exercise capacity can be useful to inform
the safe prescription of exercise programs in patients with CF,
particularly in those with advanced lung disease. Additionally,
information about requirement for oxygen supplementation
during exercise can be provided. In some health care settings,
exercise capacity can provide an objective assessment of level
of disability which can be useful for decisions about the timing
of lung transplantation and government disability support
applications. In these situations, field assessments of exercise
capacity may be suitable substitutes for the more formal
laboratory-based exercise testing.4. Exercise test: what to perform?
The use of formal CPET remains useful for determining
mechanisms of the limitation of oxygen transportation and its
impact on exercise capacity in patients with CF, however, its
uptake in the clinic is limited. Field tests, such as shuttle tests,
timed walking and step tests, which are logistically easier to
perform and require less formalised equipment, are reasonable
surrogates for incremental CPET and can determine changes in
exercise capacity such as in response to a therapeutic
intervention. In the future, new technologies such as the
LifeShirt®, may be useful to allow cardiopulmonary assess-
ments to be made in the field, though the role in clinical practice
is yet to be established [17].
In conclusion, more study is required to understand the
mechanisms of exercise limitation in CF and the optimal
prescription of exercise which accounts for the varying degrees
of severity of pulmonary disease and nutritional status. The role
of formal exercise assessments as an outcome measure for the
many new therapies currently being studied in late phase
clinical trials remains in its infancy.References
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